Drug category-wise IPM
Retail vs other channels
India's pharmaceutical industry was valued at INR 2.42 lakh crores (USD 29 billion) in 2023 and is expected to nearly double to INR 4.60 lakh crores by 2030, growing at 9.6% annually.
Four key segments drive this growth: Patented Drugs, Branded Generics, Trade Generics (TGx), and Generic Generics. As market conditions and regulations change, these segments continue to adapt, strengthening India's position as a global leader in affordable healthcare solutions.